Insulin glargine and lixisenatide Subcutaneous and Paclitaxel (Conventional)
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Paclitaxel (Conventional) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: paclitaxel
Brand name: Onxol, Taxol
Synonyms: Paclitaxel, PACLitaxel (Conventional)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-Paclitaxel Concentrate Injection
- Insulin glargine and lixisenatide Subcutaneous-Paclitaxel Intravenous
- Insulin glargine and lixisenatide Subcutaneous-Paclitaxel Novaplus
- Insulin glargine and lixisenatide Subcutaneous-Paclitaxel protein-bound
- Insulin glargine and lixisenatide Subcutaneous-Paclitaxel protein-bound Intravenous
- Insulin glargine and lixisenatide Subcutaneous-Pacnex
- Paclitaxel (Conventional)-Insulin glargine, recombinant Subcutaneous
- Paclitaxel (Conventional)-Insulin glulisine
- Paclitaxel (Conventional)-Insulin Glulisine (Cartridges and Pens)
- Paclitaxel (Conventional)-Insulin Glulisine (Vials)
- Paclitaxel (Conventional)-Insulin glulisine Subcutaneous
- Paclitaxel (Conventional)-Insulin human inhaled Inhalation